Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
International Journal of Clinical Oncology|August 29, 2006
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patientsKeigo Endo, Noboru Oriuchi, Tetsuya Higuchi, et al.
Academic Radiology|February 20, 2007
Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumorsSatoshi Hirasawa, Yoshito Tsushima, Hiroyuki Takei, et al.
Radiological Physics and Technology|December 14, 2019
Time-related study on external exposure dose of 2-deoxy-2-[F-18]fluoro-D-glucose PET for workers' safetyYasuyuki Takahashi, Shota Hosokawa, Takakiyo Tsujiguchi, et al.
American Journal of Surgery|March 15, 2006
Sentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinomaErito Mochiki, Hiroyuki Kuwano, Youichi Kamiyama, et al.
Annals of Nuclear Medicine|April 10, 2004
Diagnosis of tumor in the nasal cavity and paranasal sinuses with [11C]choline PET: comparative study with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) PETHiroshi Ninomiya, Noboru Oriuchi, Nasim Kahn, et al.
Chest|April 12, 2007
Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patientsKyoichi Kaira, Noboru Oriuchi, Yoshimi Otani, et al.
Lung Cancer (Amsterdam, Netherlands)|October 5, 2007
Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancerNoriaki Sunaga, Noboru Oriuchi, Kyoichi Kaira, et al.
Cancer Science|December 1, 2011
Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomographyArifudin Achmad, Hirofumi Hanaoka, Hiroki Yoshioka, et al.
Annals of Nuclear Medicine|August 16, 2005
Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imagingMei Tian, Hong Zhang, Tetsuya Higuchi, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 5, 2013
Fractionated radioimmunotherapy with ⁹⁰Y-labeled fully human anti-CEA antibodyHirofumi Hanaoka, Masahide Kuroki, Aiko Yamaguchi, et al.
Pageof 15